
|Articles|December 10, 2019
WCG Launches AIMS 4.1 Platform
Advertisement
WCG ACI Clinical has launched the latest iteration of its proprietary AIMS. AIMS 4.1 offers users of WCG's endpoint adjudication solutions an enhanced interface and workflow experience.
To learn more about AIMS 4.1, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
De-Risking Development: Prioritizing Robustness in Trial Design
2
New Phase II Data Suggest Maternal Nipocalimab Does Not Disrupt Infant Immune Development in Severe HDFN
3
Clinical Operations Teams Adjust to Evidence and Engagement Gaps
4
Global by Design: What 2026 Means for Sites, Sponsors, and Trial Operations
5




